The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non–small-cell lung cancer
- 1 November 2000
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 48 (4) , 1025-1033
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer.International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- The Effect of Radiotherapy on the Survival of Non-Small Cell Lung Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.Journal of Clinical Oncology, 1998
- Cost of combined modality interventions for stage III non-small-cell lung cancer.Journal of Clinical Oncology, 1997
- "Plug-in" shadow price estimates for policy analysisThe Annals of Regional Science, 1997
- The economics of lung cancer management in CanadaLung Cancer, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Efficacy and Cost Effectiveness of Adjuvant Chemotherapy in Women with Node-Negative Breast CancerNew England Journal of Medicine, 1991
- A New International Staging System for Lung CancerChest, 1986
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948